Pioglitazone improves glucose metabolism and modulates skeletal muscle TIMP-3-TACE dyad in type 2 diabetes mellitus: a randomised, double-blind, placebo-controlled, mechanistic study.
about
Artemisia scoparia enhances adipocyte development and endocrine function in vitro and enhances insulin action in vivoFactors associated with beta-cell dysfunction in type 2 diabetes: the BETADECLINE study.Effects of thiazolidinedione therapy on inflammatory markers of type 2 diabetes: a meta-analysis of randomized controlled trialsLinking Gut Microbiota and Inflammation to Obesity and Insulin Resistance.The Association of Work Stress and Glycemic Status Is Partially Mediated by Autonomic Nervous System Function: Cross-Sectional Results from the Mannheim Industrial Cohort Study (MICS).Early Clinical Detection of Pharmacologic Response in Insulin Action in a Nondiabetic Insulin-Resistant Population.Evaluation of the PPAR-γ Agonist Pioglitazone in Mild Asthma: A Double-Blind Randomized Controlled TrialFractalkine signaling in regulation of insulin secretion.Finding novel distinctions between the sAPPα-mediated anabolic biochemical pathways in Autism Spectrum Disorder and Fragile X Syndrome plasma and brain tissueThe GLP-1 receptor agonists exenatide and liraglutide activate Glucose transport by an AMPK-dependent mechanism.Nondiabetic Glucometabolic Status and Progression of Aortic Stiffness: The Whitehall II Study.Blocking iNOS and endoplasmic reticulum stress synergistically improves insulin resistance in mice.Vitamin D, sub-inflammation and insulin resistance. A window on a potential role for the interaction between bone and glucose metabolism.Enhanced insulin signaling in density-enhanced phosphatase-1 (DEP-1) knockout mice.Unfavorable inflammatory profile in adults at risk of type 2 diabetes identified by hemoglobin A1c levels according to the American Diabetes Association criteria.The inflammatory status score including IL-6, TNF-α, osteopontin, fractalkine, MCP-1 and adiponectin underlies whole-body insulin resistance and hyperglycemia in type 2 diabetes mellitus.Pharmacodynamic Effects of Low-Dose Pioglitazone in Patients with the Metabolic Syndrome without Diabetes Mellitus.Aleglitazar, a dual peroxisome proliferator-activated receptor-α/γ agonist, improves insulin sensitivity, glucose control and lipid levels in people with type 2 diabetes: findings from a randomized, double-blind trial.Renal function preservation with pioglitazone or with basal insulin as an add-on therapy for patients with type 2 diabetes mellitus.Fetuin-A levels and risk of type 2 diabetes mellitus: a systematic review and meta-analysis.Considerations on inhibition approaches for proinflammatory functions of ADAM proteases.High circulating irisin levels are associated with insulin resistance and vascular atherosclerosis in a cohort of nondiabetic adult subjects.Adipose Tissue-Derived Plasminogen Activator Inhibitor-1 Function and Regulation.Pioglitazone treatment increases food intake and decreases energy expenditure partially via hypothalamic adiponectin/adipoR1/AMPK pathway.
P2860
Q33733950-75BC6A24-F28E-4FC4-84F2-4E826996C20CQ34407830-DA0A744C-113C-411A-B782-498DD09BB09AQ35510830-2A352A74-E524-4B43-A109-9AAAA67C27BAQ36037520-7F8DC638-FB63-4DDA-9DBF-DBF1B6980813Q36105810-DA148B9E-4CA9-478E-B4A0-1FD44568D849Q36109894-70098732-747A-44D5-9836-258A5BC72CA7Q36112711-95C60DF4-8EBA-4058-A9DA-D0CC8E0C9DEBQ36121992-1CBADEEE-9B1D-498F-94C2-9011144606B5Q36925690-05D2D3FA-46A6-4750-A6F9-EB2F5C52B366Q37139985-B9D6BDBA-5D44-4ED2-BBD2-BA439502D8EBQ37713929-97FF808A-1F48-4A62-BDCC-583B7990EEFEQ38970827-D0BA2467-2D3D-43F9-B546-F8F4D85AB5EEQ39242378-BEE112DE-1F41-44C5-B2D5-8116DE1DD838Q41129993-68F2E195-66BC-40E2-BB03-BAE7350FEC8EQ43807641-A353D278-AEF7-408B-90A6-A04F03372FC8Q46833522-F377E172-0230-4412-A065-932D64464326Q47901833-921CEF95-8721-47E0-B3F7-AE811A192344Q48089449-649885CC-E130-4F49-A5CE-1A083B18AA38Q48089786-97455BD1-AC60-41B1-A625-D7269C218DC4Q50061990-E932E7A5-0A76-4F2E-8489-9DF95F665AADQ50495797-F3F6C221-1F70-4087-809B-FCD84CFCC59FQ51325833-DFABCF69-EB27-45ED-ADC9-A518A5AC399FQ51361802-6E1E8FFD-57B3-41B0-BA24-65161FBD3058Q52927184-B95FFD7C-7A3A-4B00-B6AF-79911F2C0B61
P2860
Pioglitazone improves glucose metabolism and modulates skeletal muscle TIMP-3-TACE dyad in type 2 diabetes mellitus: a randomised, double-blind, placebo-controlled, mechanistic study.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Pioglitazone improves glucose ...... controlled, mechanistic study.
@en
Pioglitazone improves glucose ...... controlled, mechanistic study.
@nl
type
label
Pioglitazone improves glucose ...... controlled, mechanistic study.
@en
Pioglitazone improves glucose ...... controlled, mechanistic study.
@nl
prefLabel
Pioglitazone improves glucose ...... controlled, mechanistic study.
@en
Pioglitazone improves glucose ...... controlled, mechanistic study.
@nl
P2093
P2860
P50
P921
P1433
P1476
Pioglitazone improves glucose ...... controlled, mechanistic study.
@en
P2093
Alberto Chavez-Velasquez
Christopher Jenkinson
Devjit Tripathy
Paolo Fanti
Ralph A Defronzo
Subhash Kamath
Teresa V Fiorentino
Zandra Perez-Cadena
P2860
P2888
P304
P356
10.1007/S00125-013-2976-Z
P577
2013-06-30T00:00:00Z